ENHABIT INC (EHAB) Stock Fundamental Analysis

NYSE:EHAB • US29332G1022

13.58 USD
+0.02 (+0.15%)
At close: Feb 25, 2026
13.58 USD
0 (0%)
After Hours: 2/25/2026, 7:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EHAB. EHAB was compared to 101 industry peers in the Health Care Providers & Services industry. While EHAB is still in line with the averages on profitability rating, there are concerns on its financial health. EHAB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year EHAB was profitable.
  • In the past year EHAB had a positive cash flow from operations.
  • In multiple years EHAB reported negative net income over the last 5 years.
  • Each year in the past 5 years EHAB had a positive operating cash flow.
EHAB Yearly Net Income VS EBIT VS OCF VS FCFEHAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

  • The Return On Assets of EHAB (-0.97%) is comparable to the rest of the industry.
  • With a Return On Equity value of -2.10%, EHAB perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.51%, EHAB is in line with its industry, outperforming 51.49% of the companies in the same industry.
  • EHAB had an Average Return On Invested Capital over the past 3 years of 3.74%. This is significantly below the industry average of 8.93%.
  • The last Return On Invested Capital (4.51%) for EHAB is above the 3 year average (3.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROIC 4.51%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
EHAB Yearly ROA, ROE, ROICEHAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • With a decent Operating Margin value of 5.96%, EHAB is doing good in the industry, outperforming 66.34% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EHAB has declined.
  • EHAB has a better Gross Margin (48.98%) than 74.26% of its industry peers.
  • In the last couple of years the Gross Margin of EHAB has remained more or less at the same level.
Industry RankSector Rank
OM 5.96%
PM (TTM) N/A
GM 48.98%
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
EHAB Yearly Profit, Operating, Gross MarginsEHAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • EHAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for EHAB has been increased compared to 1 year ago.
  • The debt/assets ratio for EHAB is higher compared to a year ago.
EHAB Yearly Shares OutstandingEHAB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EHAB Yearly Total Debt VS Total AssetsEHAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 1.87 indicates that EHAB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • EHAB has a Altman-Z score (1.87) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of EHAB is 8.01, which is on the high side as it means it would take EHAB, 8.01 years of fcf income to pay off all of its debts.
  • EHAB has a Debt to FCF ratio (8.01) which is in line with its industry peers.
  • EHAB has a Debt/Equity ratio of 0.78. This is a neutral value indicating EHAB is somewhat dependend on debt financing.
  • EHAB has a Debt to Equity ratio (0.78) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.01
Altman-Z 1.87
ROIC/WACC0.51
WACC8.79%
EHAB Yearly LT Debt VS Equity VS FCFEHAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

  • EHAB has a Current Ratio of 1.58. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.58, EHAB is doing good in the industry, outperforming 62.38% of the companies in the same industry.
  • EHAB has a Quick Ratio of 1.58. This is a normal value and indicates that EHAB is financially healthy and should not expect problems in meeting its short term obligations.
  • EHAB has a better Quick ratio (1.58) than 65.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
EHAB Yearly Current Assets VS Current LiabilitesEHAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • EHAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.30%, which is quite impressive.
  • EHAB shows a small growth in Revenue. In the last year, the Revenue has grown by 1.02%.
  • The Revenue has been decreasing by -1.07% on average over the past years.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%

3.2 Future

  • Based on estimates for the next years, EHAB will show a small growth in Earnings Per Share. The EPS will grow by 7.82% on average per year.
  • EHAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.22% yearly.
EPS Next Y170.06%
EPS Next 2Y71.42%
EPS Next 3Y45.79%
EPS Next 5Y7.82%
Revenue Next Year2.37%
Revenue Next 2Y3.26%
Revenue Next 3Y3.62%
Revenue Next 5Y5.22%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EHAB Yearly Revenue VS EstimatesEHAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EHAB Yearly EPS VS EstimatesEHAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 30.86, EHAB can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of EHAB is on the same level as its industry peers.
  • EHAB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 22.01, which indicates a rather expensive current valuation of EHAB.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EHAB is on the same level as its industry peers.
  • EHAB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.86
Fwd PE 22.01
EHAB Price Earnings VS Forward Price EarningsEHAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EHAB's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EHAB is cheaper than 65.35% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EHAB indicates a rather cheap valuation: EHAB is cheaper than 80.20% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.87
EV/EBITDA 12.44
EHAB Per share dataEHAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • EHAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EHAB's earnings are expected to grow with 45.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y71.42%
EPS Next 3Y45.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for EHAB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ENHABIT INC

NYSE:EHAB (2/25/2026, 7:00:02 PM)

After market: 13.58 0 (0%)

13.58

+0.02 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners104.3%
Inst Owner ChangeN/A
Ins Owners2.33%
Ins Owner Change0.98%
Market Cap687.28M
Revenue(TTM)1.05B
Net Income(TTM)-11.90M
Analysts81.67
Price Target11.99 (-11.71%)
Short Float %3.46%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.12%
Min EPS beat(2)23.34%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)21.77%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)6
Avg EPS beat(8)34.93%
EPS beat(12)7
Avg EPS beat(12)12.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.24%
Revenue beat(12)0
Avg Revenue beat(12)-3.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.85%
PT rev (3m)25.33%
EPS NQ rev (1m)-7.6%
EPS NQ rev (3m)-3.95%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)12.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 30.86
Fwd PE 22.01
P/S 0.66
P/FCF 11.87
P/OCF 11.03
P/B 1.21
P/tB N/A
EV/EBITDA 12.44
EPS(TTM)0.44
EY3.24%
EPS(NY)0.62
Fwd EY4.54%
FCF(TTM)1.14
FCFY8.42%
OCF(TTM)1.23
OCFY9.06%
SpS20.7
BVpS11.2
TBVpS-7.48
PEG (NY)0.18
PEG (5Y)N/A
Graham Number10.53
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROCE 5.71%
ROIC 4.51%
ROICexc 4.76%
ROICexgc 54.35%
OM 5.96%
PM (TTM) N/A
GM 48.98%
FCFM 5.53%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexgc growth 3Y-27.94%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.01
Debt/EBITDA 5.02
Cap/Depr 17.25%
Cap/Sales 0.42%
Interest Coverage 1.77
Cash Conversion 70.88%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.87
F-Score7
WACC8.79%
ROIC/WACC0.51
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
EPS Next Y170.06%
EPS Next 2Y71.42%
EPS Next 3Y45.79%
EPS Next 5Y7.82%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
Revenue Next Year2.37%
Revenue Next 2Y3.26%
Revenue Next 3Y3.62%
Revenue Next 5Y5.22%
EBIT growth 1Y60.82%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year79.24%
EBIT Next 3Y24.08%
EBIT Next 5YN/A
FCF growth 1Y632.91%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y25.6%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%

ENHABIT INC / EHAB FAQ

What is the fundamental rating for EHAB stock?

ChartMill assigns a fundamental rating of 3 / 10 to EHAB.


What is the valuation status for EHAB stock?

ChartMill assigns a valuation rating of 5 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.


Can you provide the profitability details for ENHABIT INC?

ENHABIT INC (EHAB) has a profitability rating of 4 / 10.


What is the expected EPS growth for ENHABIT INC (EHAB) stock?

The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 170.06% in the next year.